Macquarie High Income Fund Class I
IVHIX
NASDAQ
Weiss Ratings | IVHIX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Rating | ||||
Reward Index | Fair | |||
Reward Grade | C | |||
Risk Index | Good | |||
Risk Grade | B- | |||
Company Info | IVHIX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Provider | Macquarie | |||
Manager/Tenure (Years) | John P. McCarthy (3), Vivek Bommi (1) | |||
Website | http://www.macquarie.com | |||
Fund Information | IVHIX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Fund Name | Macquarie High Income Fund Class I | |||
Category | High Yield Bond | |||
Sub-Category | US Fixed Income | |||
Prospectus Objective | Growth and Income | |||
Inception Date | Apr 02, 2007 | |||
Open/Closed To New Investors | Open | |||
Minimum Initial Investment | 0.00 | |||
Minimum Subsequent Investment | -- | |||
Front End Fee | -- | |||
Back End Fee | -- | |||
Dividends and Shares | IVHIX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Dividend Yield | 6.61% | |||
Dividend | IVHIX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Dividend Yield (Forward) | -- | |||
Asset Allocation | IVHIX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Cash | 2.81% | |||
Stock | 1.78% | |||
U.S. Stock | 0.50% | |||
Non-U.S. Stock | 1.28% | |||
Bond | 90.72% | |||
U.S. Bond | 71.77% | |||
Non-U.S. Bond | 18.95% | |||
Preferred | 3.16% | |||
Convertible | 0.00% | |||
Other Net | 1.53% | |||
Price History | IVHIX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
7-Day Total Return | -0.21% | |||
30-Day Total Return | 0.19% | |||
60-Day Total Return | 1.21% | |||
90-Day Total Return | 2.94% | |||
Year to Date Total Return | 4.47% | |||
1-Year Total Return | 3.17% | |||
2-Year Total Return | 19.24% | |||
3-Year Total Return | 31.84% | |||
5-Year Total Return | 28.27% | |||
Price | IVHIX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Closing Price | -- | |||
1-Month Low Price | -- | |||
1-Month High Price | -- | |||
52-Week Low Price | -- | |||
52-Week Low Price (Date) | -- | |||
52-Week High Price | -- | |||
52-Week High Price (Date) | -- | |||
NAV | IVHIX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Nav | $5.98 | |||
1-Month Low NAV | $5.96 | |||
1-Month High NAV | $6.02 | |||
52-Week Low NAV | $5.64 | |||
52-Week Low NAV (Date) | Apr 07, 2025 | |||
52-Week High NAV | $6.22 | |||
52-Week High Price (Date) | Oct 02, 2024 | |||
Beta / Standard Deviation | IVHIX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Beta | 0.64 | |||
Standard Deviation | 6.61 | |||
Balance Sheet | IVHIX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Total Assets | 2.22B | |||
Operating Ratios | IVHIX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Expense Ratio | 0.63% | |||
Turnover Ratio | 56.00% | |||
Performance | IVHIX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Last Bull Market Total Return | 5.83% | |||
Last Bear Market Total Return | -13.05% | |||